The novel circSLC6A6/miR-1265/C2CD4A axis promotes colorectal cancer growth by suppressing p53 signaling pathway

CONCLUSION: Our results identified that circSLC6A6/miR-1265/C2CD4A axis, which was involved in CRC via the p53 signaling pathway, may serve as a therapeutic target for CRC.PMID:34656159 | DOI:10.1186/s13046-021-02126-y

Source: Clinical Colorectal Cancer - October 17, 2021 Category: Cancer & Oncology Authors: Zeyin Rong Zai Luo Zhongmao Fu Pengshan Zhang Tengfei Li Jianming Zhang Zhonglin Zhu Zhilong Yu Qi Li Zhengjun Qiu Chen Huang Source Type: research